Vedolizumab
2018-002794-21
Approved mab active
Quick answer
Vedolizumab for Ulcerative Colitis is a Approved program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 9 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Ulcerative Colitis
- Phase
- Approved
- Modality
- mab
- Status
- active